NEW YORK (GenomeWeb) – Curetis announced today that it has signed collaboration and commercialization deals with BGI Group subsidiary MGI to combine their technologies for next-generation sequencing-based infectious disease testing.

The firms said they plan to combine Curetis' Unyvero Lysator-based sample preparation technology and MGI's NGS to create a fully automated workflow that allows for the processing of any type of native clinical sample, with the subsequent NGS-based detection of microbial pathogens and genetic markers for antibiotic resistance. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.